Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event Other events
  2. 8-K Event Other events
  3. 8-K/A Event Material agreement · Other events
  4. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $18.67 ($79,360)
  5. 8-K Event Material agreement · Other events
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4/A Open-market sale Director sold 6,372 shares at $33.50 ($213,475)
  15. 8-K Event Shareholder vote results
  16. 424B5 Offering Prospectus
  17. 424B5 Offering Prospectus
  18. 4 Open-market sale Chief Technical Officer sold 12,000 shares at $20.00 ($240,000)
  19. 8-K Event Other events
  20. 4 Derivatives Options or other derivatives

Page 37 of 47 · 923 filings